Ebola may soon be a “preventable and treatable” disease after a trial of two drugs showed significantly improved survival rates, scientists have said.

Four drugs were trialled on patients in the Democratic Republic of Congo, where there is a major outbreak of the virus.

Two of those, named REGN-EB3 and mAb114, were more effective in treating the disease, the study found.

The drugs will now be used to treat Ebola patients in DR Congo, according to health officials.

The US National Institute of Allergy and Infectious Diseases (NIAID), which co-sponsored the trial, said the results are “very good news” for the fight against Ebola.

The drugs work by attacking the Ebola virus with antibodies, neutralising its impact on human cells.

They were developed using antibodies harvested from survivors of

Read More At Article Source | Article Attribution